|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls008423667 |
| 003 |
SK-MaSNL |
| 005 |
20260303065900.0 |
| 008 |
140303c2005 xo wrzp 0 0slo |
| 015 |
|
|
|a SNBRB2006/01
|2 snkbucl
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.895.8-085
|2 1997
|
| 080 |
|
|
|a 615.214
|2 1997
|
| 080 |
|
|
|a 616.831-091
|2 1997
|
| 245 |
0 |
0 |
|a Vplyv antipsychotík na morfológiu mozgu pri liečbe prvej epizódy psychózy
|c [spracoval] (mos)
|
| 300 |
|
|
|b Fotogr.
|
| 500 |
|
|
|a Prevzaté: J. A. Lieberman a spol., Arch Gen Psychiatry 2005, 62: 361 - 375)
|
| 650 |
0 |
7 |
|a schizofrénia
|x farmakoterapia
|2 snkbucl
|9 871549
|
| 650 |
0 |
7 |
|a sivá hmota mozgu
|x morfológia
|2 snkbucl
|9 1066524
|
| 650 |
0 |
7 |
|a antipsychotiká
|2 snkbucl
|9 14209
|
| 650 |
0 |
7 |
|a olanzapín
|2 snkbucl
|9 1066525
|
| 650 |
0 |
7 |
|a haloperidol
|2 snkbucl
|9 1066526
|
| 773 |
0 |
|
|t Zdravotnícke noviny
|g Roč. X, č. 35 (2005)
|x 1335-4477
|
| 773 |
0 |
8 |
|t Lekárske listy
|g Č. 35 (2005), s. 34-36
|
| 852 |
|
|
|a SNK
|b KIS3GCP
|
| 958 |
|
|
|a ME
|2 snkbucl
|
| 999 |
|
|
|c 1753130
|d 1755060
|
